Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 257

1.

Increase of invasive meningococcal serogroup W disease in Europe, 2013 to 2017.

Krone M, Gray S, Abad R, Skoczyńska A, Stefanelli P, van der Ende A, Tzanakaki G, Mölling P, João Simões M, Křížová P, Emonet S, Caugant DA, Toropainen M, Vazquez J, Waśko I, Knol MJ, Jacobsson S, Rodrigues Bettencourt C, Musilek M, Born R, Vogel U, Borrow R.

Euro Surveill. 2019 Apr;24(14). doi: 10.2807/1560-7917.ES.2019.24.14.1800245.

2.

Molecular studies of meningococcal and pneumococcal meningitis patients in Ethiopia.

Mihret W, Sletbakk Brusletto B, Øvstebø R, Siebke Troseid AM, Norheim G, Merid Y, Kassu A, Abebe W, Ayele S, Silamsaw Asres M, Yamuah L, Aseffa A, Petros B, Caugant DA, Brandtzaeg P.

Innate Immun. 2019 Apr;25(3):158-167. doi: 10.1177/1753425918806363.

PMID:
30894090
3.

Phylogenetic relationships and regional spread of meningococcal strains in the meningitis belt, 2011-2016.

Topaz N, Caugant DA, Taha MK, Brynildsrud OB, Debech N, Hong E, Deghmane AE, Ouédraogo R, Ousmane S, Gamougame K, Njanpop-Lafourcade BM, Diarra S, Fox LM, Wang X.

EBioMedicine. 2019 Mar;41:488-496. doi: 10.1016/j.ebiom.2019.02.054. Epub 2019 Mar 4.

4.

Integrated analysis of population genomics, transcriptomics and virulence provides novel insights into Streptococcus pyogenes pathogenesis.

Kachroo P, Eraso JM, Beres SB, Olsen RJ, Zhu L, Nasser W, Bernard PE, Cantu CC, Saavedra MO, Arredondo MJ, Strope B, Do H, Kumaraswami M, Vuopio J, Gröndahl-Yli-Hannuksela K, Kristinsson KG, Gottfredsson M, Pesonen M, Pensar J, Davenport ER, Clark AG, Corander J, Caugant DA, Gaini S, Magnussen MD, Kubiak SL, Nguyen HAT, Long SW, Porter AR, DeLeo FR, Musser JM.

Nat Genet. 2019 Mar;51(3):548-559. doi: 10.1038/s41588-018-0343-1. Epub 2019 Feb 18.

PMID:
30778225
5.

New molecular tools for meningitis diagnostics in Ethiopia - a necessary step towards improving antimicrobial prescription.

Bårnes GK, Gudina EK, Berhane M, Abdissa A, Tesfaw G, Abebe G, Feruglio SL, Caugant DA, Jørgensen HJ.

BMC Infect Dis. 2018 Dec 20;18(1):684. doi: 10.1186/s12879-018-3589-4.

6.

The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations.

Acevedo R, Bai X, Borrow R, Caugant DA, Carlos J, Ceyhan M, Christensen H, Climent Y, De Wals P, Dinleyici EC, Echaniz-Aviles G, Hakawi A, Kamiya H, Karachaliou A, Lucidarme J, Meiring S, Mironov K, Sáfadi MAP, Shao Z, Smith V, Steffen R, Stenmark B, Taha MK, Trotter C, Vázquez JA, Zhu B.

Expert Rev Vaccines. 2019 Jan;18(1):15-30. doi: 10.1080/14760584.2019.1557520. Epub 2018 Dec 27. Review.

PMID:
30526162
7.

Narrative review of methods and findings of recent studies on the carriage of meningococci and other Neisseria species in the African Meningitis Belt.

Greenwood BM, Aseffa A, Caugant DA, Diallo K, Kristiansen PA, Maiden MCJ, Stuart JM, Trotter CL.

Trop Med Int Health. 2019 Feb;24(2):143-154. doi: 10.1111/tmi.13185. Epub 2018 Dec 6. Review.

8.

Metagenomics for investigation of an unusual meningococcal outbreak.

Caugant DA.

Lancet Infect Dis. 2018 Dec;18(12):1295-1296. doi: 10.1016/S1473-3099(18)30499-7. Epub 2018 Oct 15. No abstract available.

PMID:
30337261
9.

Establishment of the European meningococcal strain collection genome library (EMSC-GL) for the 2011 to 2012 epidemiological year.

Bratcher HB, Brehony C, Heuberger S, Pieridou-Bagatzouni D, Křížová P, Hoffmann S, Toropainen M, Taha MK, Claus H, Tzanakaki G, Erdôsi T, Galajeva J, van der Ende A, Skoczyńska A, Pana M, Vaculíková A, Paragi M, Maiden MC, Caugant DA.

Euro Surveill. 2018 May;23(20). doi: 10.2807/1560-7917.ES.2018.23.20.17-00474.

10.

Acquisition of virulence genes by a carrier strain gave rise to the ongoing epidemics of meningococcal disease in West Africa.

Brynildsrud OB, Eldholm V, Bohlin J, Uadiale K, Obaro S, Caugant DA.

Proc Natl Acad Sci U S A. 2018 May 22;115(21):5510-5515. doi: 10.1073/pnas.1802298115. Epub 2018 May 7.

11.

Genotypic and Phenotypic Characterization of the O-Linked Protein Glycosylation System Reveals High Glycan Diversity in Paired Meningococcal Carriage Isolates.

Børud B, Bårnes GK, Brynildsrud OB, Fritzsønn E, Caugant DA.

J Bacteriol. 2018 Jul 25;200(16). pii: e00794-17. doi: 10.1128/JB.00794-17. Print 2018 Aug 15.

12.

Predicting the Susceptibility of Meningococcal Serogroup B Isolates to Bactericidal Antibodies Elicited by Bivalent rLP2086, a Novel Prophylactic Vaccine.

McNeil LK, Donald RGK, Gribenko A, French R, Lambert N, Harris SL, Jones TR, Li S, Zlotnick G, Vogel U, Claus H, Abad R, Vazquez JA, Borrow R, Findlow J, Taha MK, Deghmane AE, Caugant DA, Kriz P, Musilek M, Wang X, Vuong J, Mayer LW, Pride MW, Jansen KU, Anderson AS.

MBio. 2018 Mar 13;9(2). pii: e00036-18. doi: 10.1128/mBio.00036-18.

13.

Four years of case-based surveillance of meningitis following the introduction of MenAfriVac in Moissala, Chad: lessons learned.

Page AL, Coldiron ME, Gamougam K, Acyl MA, Tamadji M, Lastrucci C, Hurtado N, Tehoua FC, Fermon F, Caugant DA, Porten K.

Trop Med Int Health. 2017 Dec;22(12):1561-1568. doi: 10.1111/tmi.12987. Epub 2017 Oct 26.

14.

Outer membrane phospholipase A's roles in Helicobacter pylori acid adaptation.

Vollan HS, Tannæs T, Caugant DA, Vriend G, Bukholm G.

Gut Pathog. 2017 Jun 12;9:36. doi: 10.1186/s13099-017-0184-y. eCollection 2017.

15.

Whole genome sequencing reveals within-host genetic changes in paired meningococcal carriage isolates from Ethiopia.

Bårnes GK, Brynildsrud OB, Børud B, Workalemahu B, Kristiansen PA, Beyene D, Aseffa A, Caugant DA.

BMC Genomics. 2017 May 25;18(1):407. doi: 10.1186/s12864-017-3806-3.

16.

Hierarchical genomic analysis of carried and invasive serogroup A Neisseria meningitidis during the 2011 epidemic in Chad.

Diallo K, Gamougam K, Daugla DM, Harrison OB, Bray JE, Caugant DA, Lucidarme J, Trotter CL, Hassan-King M, Stuart JM, Manigart O, Greenwood BM, Maiden MCJ.

BMC Genomics. 2017 May 22;18(1):398. doi: 10.1186/s12864-017-3789-0.

17.

Meningococcal disease in the Middle East and Africa: Findings and updates from the Global Meningococcal Initiative.

Borrow R, Caugant DA, Ceyhan M, Christensen H, Dinleyici EC, Findlow J, Glennie L, Von Gottberg A, Kechrid A, Vázquez Moreno J, Razki A, Smith V, Taha MK, Tali-Maamar H, Zerouali K; Global Meningococcal Initiative (GMI).

J Infect. 2017 Jul;75(1):1-11. doi: 10.1016/j.jinf.2017.04.007. Epub 2017 Apr 25. Review.

18.

The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection.

Borrow R, Alarcón P, Carlos J, Caugant DA, Christensen H, Debbag R, De Wals P, Echániz-Aviles G, Findlow J, Head C, Holt D, Kamiya H, Saha SK, Sidorenko S, Taha MK, Trotter C, Vázquez Moreno JA, von Gottberg A, Sáfadi MA; Global Meningococcal Initiative.

Expert Rev Vaccines. 2017 Apr;16(4):313-328. doi: 10.1080/14760584.2017.1258308. Epub 2016 Nov 22. Review.

PMID:
27820969
19.

Prevalence and epidemiology of meningococcal carriage in Southern Ethiopia prior to implementation of MenAfriVac, a conjugate vaccine.

Bårnes GK, Kristiansen PA, Beyene D, Workalemahu B, Fissiha P, Merdekios B, Bohlin J, Préziosi MP, Aseffa A, Caugant DA.

BMC Infect Dis. 2016 Nov 4;16(1):639.

20.

Whole-Genome Characterization of Epidemic Neisseria meningitidis Serogroup C and Resurgence of Serogroup W, Niger, 2015.

Kretz CB, Retchless AC, Sidikou F, Issaka B, Ousmane S, Schwartz S, Tate AH, Pana A, Njanpop-Lafourcade BM, Nzeyimana I, Nse RO, Deghmane AE, Hong E, Brynildsrud OB, Novak RT, Meyer SA, Oukem-Boyer OOM, Ronveaux O, Caugant DA, Taha MK, Wang X; Niger Response Team.

Emerg Infect Dis. 2016 Oct;22(10):1762-1768. doi: 10.3201/eid2210.160468.

21.

Invasive Meningococcal Meningitis Serogroup C Outbreak in Northwest Nigeria, 2015 - Third Consecutive Outbreak of a New Strain.

Chow J, Uadiale K, Bestman A, Kamau C, Caugant DA, Shehu A, Greig J.

PLoS Curr. 2016 Jul 7;8. pii: ecurrents.outbreaks.06d10b6b4e690917d8b0a04268906143. doi: 10.1371/currents.outbreaks.06d10b6b4e690917d8b0a04268906143.

22.

Evaluation of Pastorex meningitis kit performance for the rapid identification of Neisseria meningitidis serogroup C in Nigeria.

Uadiale K, Bestman A, Kamau C, Caugant DA, Greig J.

Trans R Soc Trop Med Hyg. 2016 Jul;110(7):381-5. doi: 10.1093/trstmh/trw046.

23.

Epidemiology of invasive group A streptococcal infections in Norway 2010-2014: A retrospective cohort study.

Naseer U, Steinbakk M, Blystad H, Caugant DA.

Eur J Clin Microbiol Infect Dis. 2016 Oct;35(10):1639-48. doi: 10.1007/s10096-016-2704-y. Epub 2016 Jun 16.

PMID:
27311458
24.

Salivary and Serum Antibody Response Against Neisseria meningitidis After Vaccination With Conjugate Polysaccharide Vaccines in Ethiopian Volunteers.

Bårnes GK, Workalemahu B, Kristiansen PA, Beyene D, Merdekios B, Fissiha P, Aseffa A, Caugant DA, Naess LM.

Scand J Immunol. 2016 Aug;84(2):118-29. doi: 10.1111/sji.12451.

25.

Surveillance of Bacterial Meningitis, Ethiopia, 2012-2013.

Mihret W, Lema T, Merid Y, Kassu A, Abebe W, Moges B, Tenna A, Woldegebriel F, Yidnekachew M, Mekonnen W, Ahmed A, Yamuah L, Silamsaw M, Petros B, Oksnes J, Rosenqvist E, Ayele S, Aseffa A, Caugant DA, Norheim G.

Emerg Infect Dis. 2016 Jan;22(1):75-8. doi: 10.3201/eid2201.150432.

26.

Serogroup A meningococcal conjugate vaccines in Africa.

Kristiansen PA, Jørgensen HJ, Caugant DA.

Expert Rev Vaccines. 2015;14(11):1441-58. doi: 10.1586/14760584.2015.1084232. Epub 2015 Aug 31. Review.

PMID:
26358167
27.

Decreased Carriage and Genetic Shifts in the Streptococcus pneumoniae Population After Changing the Seven-valent to the Thirteen-valent Pneumococcal Vaccine in Norway.

Steens A, Caugant DA, Aaberge IS, Vestrheim DF.

Pediatr Infect Dis J. 2015 Aug;34(8):875-83. doi: 10.1097/INF.0000000000000751.

PMID:
26020410
28.

Genomic Analysis of the Evolution and Global Spread of Hyper-invasive Meningococcal Lineage 5.

Harrison OB, Bray JE, Maiden MC, Caugant DA.

EBioMedicine. 2015 Mar 1;2(3):234-243.

29.

Development and Evaluation of a Multiplex Microsphere Assay for Quantitation of IgG and IgA Antibodies against Neisseria meningitidis Serogroup A, C, W, and Y Polysaccharides.

Bårnes GK, Kristiansen PA, Caugant DA, Næss LM.

Clin Vaccine Immunol. 2015 Jul;22(7):697-705. doi: 10.1128/CVI.00087-15. Epub 2015 Apr 29.

30.

Sequential outbreaks due to a new strain of Neisseria meningitidis serogroup C in northern Nigeria, 2013-14.

Funk A, Uadiale K, Kamau C, Caugant DA, Ango U, Greig J.

PLoS Curr. 2014 Dec 29;6. pii: ecurrents.outbreaks.b50c2aaf1032b3ccade0fca0b63ee518. doi: 10.1371/currents.outbreaks.b50c2aaf1032b3ccade0fca0b63ee518.

31.

Continuing effectiveness of serogroup A meningococcal conjugate vaccine, Chad, 2013.

Gamougam K, Daugla DM, Toralta J, Ngadoua C, Fermon F, Page AL, Djingarey MH, Caugant DA, Manigart O, Trotter CL, Stuart JM, Greenwood BM.

Emerg Infect Dis. 2015 Jan;21(1):115-8. doi: 10.3201/eid2101.140256.

32.

Persistent low carriage of serogroup A Neisseria meningitidis two years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac.

Kristiansen PA, Ba AK, Ouédraogo AS, Sanou I, Ouédraogo R, Sangaré L, Diomandé F, Kandolo D, Saga IM, Misegades L, Clark TA, Préziosi MP, Caugant DA.

BMC Infect Dis. 2014 Dec 4;14:663. doi: 10.1186/s12879-014-0663-4.

33.

Evolution of extensively drug-resistant Mycobacterium tuberculosis from a susceptible ancestor in a single patient.

Eldholm V, Norheim G, von der Lippe B, Kinander W, Dahle UR, Caugant DA, Mannsåker T, Mengshoel AT, Dyrhol-Riise AM, Balloux F.

Genome Biol. 2014 Nov 7;15(11):490. doi: 10.1186/s13059-014-0490-3.

34.

Detection of Legionella by cultivation and quantitative real-time polymerase chain reaction in biological waste water treatment plants in Norway.

Lund V, Fonahn W, Pettersen JE, Caugant DA, Ask E, Nysaeter A.

J Water Health. 2014 Sep;12(3):543-54. doi: 10.2166/wh.2014.063.

PMID:
25252358
35.

Multilocus sequence typing and ftsI sequencing: a powerful tool for surveillance of penicillin-binding protein 3-mediated beta-lactam resistance in nontypeable Haemophilus influenzae.

Skaare D, Anthonisen IL, Caugant DA, Jenkins A, Steinbakk M, Strand L, Sundsfjord A, Tveten Y, Kristiansen BE.

BMC Microbiol. 2014 May 20;14:131. doi: 10.1186/1471-2180-14-131.

36.

Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derived from 3,615 genome sequences.

Nasser W, Beres SB, Olsen RJ, Dean MA, Rice KA, Long SW, Kristinsson KG, Gottfredsson M, Vuopio J, Raisanen K, Caugant DA, Steinbakk M, Low DE, McGeer A, Darenberg J, Henriques-Normark B, Van Beneden CA, Hoffmann S, Musser JM.

Proc Natl Acad Sci U S A. 2014 Apr 29;111(17):E1768-76. doi: 10.1073/pnas.1403138111. Epub 2014 Apr 14.

37.

A broadly-protective vaccine against meningococcal disease in sub-Saharan Africa based on generalized modules for membrane antigens (GMMA).

Koeberling O, Ispasanie E, Hauser J, Rossi O, Pluschke G, Caugant DA, Saul A, MacLennan CA.

Vaccine. 2014 May 13;32(23):2688-95. doi: 10.1016/j.vaccine.2014.03.068. Epub 2014 Apr 3.

38.

Implications of differential age distribution of disease-associated meningococcal lineages for vaccine development.

Brehony C, Trotter CL, Ramsay ME, Chandra M, Jolley KA, van der Ende A, Carion F, Berthelsen L, Hoffmann S, Harðardóttir H, Vazquez JA, Murphy K, Toropainen M, Caniça M, Ferreira E, Diggle M, Edwards GF, Taha MK, Stefanelli P, Kriz P, Gray SJ, Fox AJ, Jacobsson S, Claus H, Vogel U, Tzanakaki G, Heuberger S, Caugant DA, Frosch M, Maiden MC.

Clin Vaccine Immunol. 2014 Jun;21(6):847-53. doi: 10.1128/CVI.00133-14. Epub 2014 Apr 2.

39.

Variability of genes encoding surface proteins used as vaccine antigens in meningococcal endemic and epidemic strain panels from Norway.

Holst J, Comanducci M, Bambini S, Muzzi A, Comandi S, Oksnes J, DeTora L, Pizza M, Rappuoli R, Caugant DA.

Vaccine. 2014 May 13;32(23):2722-31. doi: 10.1016/j.vaccine.2014.02.068. Epub 2014 Mar 12.

PMID:
24631075
40.

Human antibody responses to pneumococcal surface protein A and capsular polysaccharides during acute and convalescent stages of invasive disease in adult patients.

Kolberg J, Aase A, Naess LM, Aaberge IS, Caugant DA.

Pathog Dis. 2014 Feb;70(1):40-50. doi: 10.1111/2049-632X.12106. Epub 2013 Nov 21.

PMID:
24151210
41.

Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study [corrected].

Daugla DM, Gami JP, Gamougam K, Naibei N, Mbainadji L, Narbé M, Toralta J, Kodbesse B, Ngadoua C, Coldiron ME, Fermon F, Page AL, Djingarey MH, Hugonnet S, Harrison OB, Rebbetts LS, Tekletsion Y, Watkins ER, Hill D, Caugant DA, Chandramohan D, Hassan-King M, Manigart O, Nascimento M, Woukeu A, Trotter C, Stuart JM, Maiden M, Greenwood BM.

Lancet. 2014 Jan 4;383(9911):40-47. doi: 10.1016/S0140-6736(13)61612-8. Epub 2013 Sep 12. Erratum in: Lancet. 2014 Jan 4;383(9911):30.

42.

Phenotypic and genotypic characterization of meningococcal carriage and disease isolates in Burkina Faso after mass vaccination with a serogroup a conjugate vaccine.

Kristiansen PA, Ba AK, Sanou I, Ouédraogo AS, Ouédraogo R, Sangaré L, Diomandé F, Kandolo D, Thomas JD, Clark TA, Laforce M, Caugant DA.

BMC Infect Dis. 2013 Aug 2;13:363. doi: 10.1186/1471-2334-13-363.

43.

A multi-country evaluation of Neisseria meningitidis serogroup B factor H-binding proteins and implications for vaccine coverage in different age groups.

Hoiseth SK, Murphy E, Andrew L, Vogel U, Frosch M, Hellenbrand W, Abad R, Vazquez JA, Borrow R, Findlow J, Taha MK, Deghmane AE, Caugant DA, Kriz P, Musilek M, Mayer LW, Wang X, Macneil JR, York L, Tan CY, Jansen KU, Anderson AS.

Pediatr Infect Dis J. 2013 Oct;32(10):1096-101. doi: 10.1097/INF.0b013e31829aa63b.

PMID:
23694830
44.

Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment.

Vogel U, Taha MK, Vazquez JA, Findlow J, Claus H, Stefanelli P, Caugant DA, Kriz P, Abad R, Bambini S, Carannante A, Deghmane AE, Fazio C, Frosch M, Frosi G, Gilchrist S, Giuliani MM, Hong E, Ledroit M, Lovaglio PG, Lucidarme J, Musilek M, Muzzi A, Oksnes J, Rigat F, Orlandi L, Stella M, Thompson D, Pizza M, Rappuoli R, Serruto D, Comanducci M, Boccadifuoco G, Donnelly JJ, Medini D, Borrow R.

Lancet Infect Dis. 2013 May;13(5):416-25. doi: 10.1016/S1473-3099(13)70006-9. Epub 2013 Feb 13.

PMID:
23414709
45.

Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity.

Kristiansen PA, Diomandé F, Ba AK, Sanou I, Ouédraogo AS, Ouédraogo R, Sangaré L, Kandolo D, Aké F, Saga IM, Clark TA, Misegades L, Martin SW, Thomas JD, Tiendrebeogo SR, Hassan-King M, Djingarey MH, Messonnier NE, Préziosi MP, Laforce FM, Caugant DA.

Clin Infect Dis. 2013 Feb;56(3):354-63. doi: 10.1093/cid/cis892. Epub 2012 Oct 19.

PMID:
23087396
46.

Carriage of Neisseria lactamica in 1- to 29-year-old people in Burkina Faso: epidemiology and molecular characterization.

Kristiansen PA, Diomandé F, Ouédraogo R, Sanou I, Sangaré L, Ouédraogo AS, Ba AK, Kandolo D, Dolan Thomas J, Clark TA, Préziosi MP, Laforce FM, Caugant DA.

J Clin Microbiol. 2012 Dec;50(12):4020-7. doi: 10.1128/JCM.01717-12. Epub 2012 Oct 3.

47.

Molecular characterization of invasive meningococcal isolates from countries in the African meningitis belt before introduction of a serogroup A conjugate vaccine.

Caugant DA, Kristiansen PA, Wang X, Mayer LW, Taha MK, Ouédraogo R, Kandolo D, Bougoudogo F, Sow S, Bonte L.

PLoS One. 2012;7(9):e46019. doi: 10.1371/journal.pone.0046019. Epub 2012 Sep 27.

48.

Molecular characterization of clinical and environmental isolates of Legionella pneumophila in Norway, 2001-2008.

Wedege E, Bolstad K, Borgen K, Fritzsønn E, Caugant DA.

Scand J Infect Dis. 2013 Jan;45(1):59-64. doi: 10.3109/00365548.2012.710855. Epub 2012 Sep 19.

PMID:
22992204
49.

Interlaboratory standardization of the sandwich enzyme-linked immunosorbent assay designed for MATS, a rapid, reproducible method for estimating the strain coverage of investigational vaccines.

Plikaytis BD, Stella M, Boccadifuoco G, DeTora LM, Agnusdei M, Santini L, Brunelli B, Orlandi L, Simmini I, Giuliani M, Ledroit M, Hong E, Taha MK, Ellie K, Rajam G, Carlone GM, Claus H, Vogel U, Borrow R, Findlow J, Gilchrist S, Stefanelli P, Fazio C, Carannante A, Oksnes J, Fritzsønn E, Klem AM, Caugant DA, Abad R, Vázquez JA, Rappuoli R, Pizza M, Donnelly JJ, Medini D.

Clin Vaccine Immunol. 2012 Oct;19(10):1609-17. Epub 2012 Aug 8.

50.

Decline in early childhood respiratory tract infections in the Norwegian mother and child cohort study after introduction of pneumococcal conjugate vaccination.

Magnus MC, Vestrheim DF, Nystad W, Håberg SE, Stigum H, London SJ, Bergsaker MA, Caugant DA, Aaberge IS, Nafstad P.

Pediatr Infect Dis J. 2012 Sep;31(9):951-5.

Supplemental Content

Loading ...
Support Center